Next Article in Journal
Expression, Distribution and Role of Aquaporin Water Channels in Human and Animal Stomach and Intestines
Next Article in Special Issue
Implications of Hypoxia in Breast Cancer Metastasis to Bone
Previous Article in Journal
Cleome rutidosperma and Euphorbia thymifolia Suppress Inflammatory Response via Upregulation of Phase II Enzymes and Modulation of NF-κB and JNK Activation in LPS-Stimulated BV2 Microglia
Previous Article in Special Issue
In Vitro Co-Culture Models of Breast Cancer Metastatic Progression towards Bone
Review

Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?

1
Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal
2
Oncology Division, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, 1649-028 Lisbon, Portugal
*
Author to whom correspondence should be addressed.
Academic Editors: Dario Marchetti and Maria Alfonsina Desiderio
Int. J. Mol. Sci. 2016, 17(9), 1415; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17091415
Received: 30 June 2016 / Revised: 6 August 2016 / Accepted: 19 August 2016 / Published: 27 August 2016
(This article belongs to the Special Issue Cellular and Molecular Mechanisms of Bone Metastasis)
Bone metastases ultimately result from a complex interaction between cancer cells and bone microenvironment. However, prior to the colonization of the bone, cancer cells must succeed through a series of steps that will allow them to detach from the primary tumor, enter into circulation, recognize and adhere to specific endothelium, and overcome dormancy. We now know that as important as the metastatic cascade, tumor cells prime the secondary organ microenvironment prior to their arrival, reflecting the existence of specific metastasis-initiating cells in the primary tumor and circulating osteotropic factors. The deep comprehension of the molecular mechanisms of bone metastases may allow the future development of specific anti-tumoral therapies, but so far the approved and effective therapies for bone metastatic disease are mostly based in bone-targeted agents, like bisphosphonates, denosumab and, for prostate cancer, radium-223. Bisphosphonates and denosumab have proven to be effective in blocking bone resorption and decreasing morbidity; furthermore, in the adjuvant setting, these agents can decrease bone relapse after breast cancer surgery in postmenopausal women. In this review, we will present and discuss some examples of applied knowledge from the bench to the bed side in the field of bone metastasis. View Full-Text
Keywords: bone metastases; vicious cycle of bone metastases; osteotropic factors; pre-metastatic niche; bone-targeted agents; bisphosphonates; denosumab; radium-223 bone metastases; vicious cycle of bone metastases; osteotropic factors; pre-metastatic niche; bone-targeted agents; bisphosphonates; denosumab; radium-223
Show Figures

Graphical abstract

MDPI and ACS Style

Casimiro, S.; Ferreira, A.R.; Mansinho, A.; Alho, I.; Costa, L. Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside? Int. J. Mol. Sci. 2016, 17, 1415. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17091415

AMA Style

Casimiro S, Ferreira AR, Mansinho A, Alho I, Costa L. Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside? International Journal of Molecular Sciences. 2016; 17(9):1415. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17091415

Chicago/Turabian Style

Casimiro, Sandra, Arlindo R. Ferreira, André Mansinho, Irina Alho, and Luis Costa. 2016. "Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?" International Journal of Molecular Sciences 17, no. 9: 1415. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17091415

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop